View Single Post
Old 09-18-2016, 01:31 PM
Blackfeather Blackfeather is offline
Member
 
Join Date: Jun 2014
Posts: 175
8 yr Member
Blackfeather Blackfeather is offline
Member
 
Join Date: Jun 2014
Posts: 175
8 yr Member
Default

Quote:
Originally Posted by Sandgroper View Post
Yes, the Herald Sun newspaper article is correct. This is Phase 1 and 2a (safety, tolerability and efficacy) of a world-first trial injecting parthenogenetic stem cells into the brains of 12 humans. Phase 1 and 2a is being conducted over a 12 month + period, the first candidate underwent surgery in July 2016 and the second is now being prepped for surgery Sept/Oct. The trial is being conducted at the Royal Melbourne Hospital under the leadership of neurologist Dr Andrew Evans and neurosurgeon Dr Girish Nair. Phase 3 and 4 double-blind placebo is expected to follow if the outcome of Phase 1 and 2a is successful.
Just wondering, how would they conduct a double blind placebo controlled clinical trial that involves deep brain surgery?
Blackfeather is offline   Reply With QuoteReply With Quote